Clinical Results of Odyliresin (Iresine Celosia) in Symptomatic Benign Prostatic Hyperplasia

NCT02977832 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Benign Prostatic Hypertrophy With Outflow Obstruction
Benign Prostatic Hyperplasia

Interventions

DIETARY_SUPPLEMENT: Odyliresin
DRUG: Alfuzosin

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia